Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

iRhythm Technologies Inc

Healthcare US IRTC

120.53USD
-3.22(2.60%)

Last update at 2026-03-10T20:15:00Z

Day Range

120.14123.80
LowHigh

52 Week Range

70.24124.11
LowHigh

Fundamentals

  • Previous Close 123.75
  • Market Cap2773.31M
  • Volume380821
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-92.14800M
  • Revenue TTM513.17M
  • Revenue Per Share TTM16.71
  • Gross Profit TTM 281.63M
  • Diluted EPS TTM-4.22

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -115.88600M -100.99400M -43.60100M -54.50300M -48.23600M
Minority interest - - - - -
Net income -116.15500M -101.36100M -43.83000M -54.56800M -48.28000M
Selling general administrative 322.20M 274.84M 197.23M 179.52M 131.58M
Selling and marketing expenses - - - - -
Gross profit 281.63M 213.57M 194.89M 162.07M 108.71M
Reconciled depreciation 19.61M 9.84M 6.90M 3.44M 2.27M
Ebit -87.17600M -99.94300M -43.67300M -54.75500M -44.36100M
Ebitda -85.14000M -99.82500M -42.08200M -52.86000M -42.09200M
Depreciation and amortization 2.04M 0.12M 1.59M 1.90M 2.27M
Non operating income net other 2.04M - 1.59M 1.90M -1.50300M
Operating income -87.17600M -99.94300M -43.67300M -54.75500M -43.61800M
Other operating expenses 498.10M 422.77M 308.84M 269.31M 190.91M
Interest expense 4.14M 1.17M 1.52M 1.64M 3.12M
Tax provision 0.27M 0.37M 0.23M 0.07M 0.04M
Interest income - - - 1.64M 3.12M
Net interest income -4.13800M -1.16900M -1.51900M -1.64300M -3.11500M
Extraordinary items - - - - -
Non recurring 26.61M - - - -
Other items - - - - -
Income tax expense 0.27M 0.37M 0.23M 0.07M 0.04M
Total revenue 410.92M 322.82M 265.17M 214.55M 147.29M
Total operating expenses 368.81M 313.51M 238.56M 216.82M 152.33M
Cost of revenue 129.29M 109.26M 70.28M 52.48M 38.58M
Total other income expense net -28.71000M -1.05100M 0.07M 0.25M -1.50300M
Discontinued operations - - - - -
Net income from continuing ops -116.15500M -101.36100M -43.83000M -54.56800M -48.28000M
Net income applicable to common shares -116.15500M -101.36100M -43.83000M -54.56800M -50.37800M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 433.14M 448.22M 462.97M 511.74M 306.21M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 21.59M 10.55M 9.69M 7.36M 4.34M
Total liab 223.05M 208.41M 183.45M 170.13M 170.80M
Total stockholder equity 210.10M 239.81M 279.51M 341.61M 135.41M
Deferred long term liab - - - - -
Other current liab 83.36M 65.50M 51.49M 40.53M 32.71M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings -645.60600M -522.20000M -406.04500M -304.68400M -260.39300M
Other liab - 1.31M 0.70M 1.83M -
Good will 0.86M 0.86M 0.86M 0.86M 0.86M
Other assets - 22.25M 16.05M 98.81M 7.94M
Cash 36.17M 78.83M 127.56M 88.63M 20.46M
Cash and equivalents - - - - -
Total current liabilities 107.37M 89.10M 87.85M 65.67M 52.07M
Current deferred revenue 3.31M 3.05M 3.05M 0.93M 1.25M
Net debt 93.65M 52.21M -9.85100M 33.84M 108.13M
Short term debt 15.16M 13.03M 22.81M 19.84M 9.86M
Short long term debt - - 11.67M 11.67M 1.94M
Short long term debt total 129.82M 131.04M 117.71M 122.47M 128.59M
Other stockholder equity 855.78M 762.38M 685.59M 646.26M 395.69M
Property plant equipment - 75.67M 140.53M 34.25M 116.59M
Total current assets 230.81M 288.77M 305.52M 377.82M 172.79M
Long term investments - - - 0.00000M 8.03M
Net tangible assets - 238.95M 278.65M 340.75M 134.55M
Short term investments 97.59M 134.31M 111.57M 246.59M 120.09M
Net receivables 61.48M 49.92M 46.43M 29.93M 23.87M
Long term debt 34.95M 34.94M 9.69M 21.34M 32.99M
Inventory 13.97M 15.15M 10.27M 5.31M 4.04M
Accounts payable 5.54M 7.52M 10.51M 4.37M 8.24M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.11200M -0.39600M -0.06100M 0.01M 0.08M
Additional paid in capital - - - - -
Common stock total equity - 0.03M - 0.03M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - -522.20000M - -304.68400M -260.39300M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 45.04M 22.25M 16.05M 14.09M 7.94M
Deferred long term asset charges - - - - -
Non current assets total 202.33M 159.45M 157.44M 133.91M 133.42M
Capital lease obligations 94.87M 96.10M 96.35M 89.46M 93.66M
Long term debt total - 34.94M - 21.34M 32.99M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -22.60400M 133.33M -118.84000M -68.81700M 39.30M
Change to liabilities 11.48M 8.25M -2.57300M 11.61M 10.58M
Total cashflows from investing activities -52.43400M 105.26M -132.39100M -89.27400M 34.12M
Net borrowings 13.53M -11.66700M -1.94400M -1.94400M 0.86M
Total cash from financing activities 26.72M -28.57700M 214.32M 111.58M 6.30M
Change to operating activities 4.43M 4.05M -12.68700M -4.66700M 9.31M
Net income -116.15500M -101.36100M -43.83000M -54.56800M -48.28000M
Change in cash -48.73000M 38.93M 68.17M 0.44M 11.35M
Begin period cash flow 127.56M 88.63M 20.46M 20.02M 8.67M
End period cash flow 78.83M 127.56M 88.63M 20.46M 20.02M
Total cash from operating activities -23.01200M -37.75300M -13.75900M -21.86300M -29.06800M
Issuance of capital stock 0.00000M 0.00000M 206.03M 116.86M 0.00000M
Depreciation 19.61M 9.84M 6.90M 3.44M 2.27M
Other cashflows from investing activities - - - -68.81700M 39.32M
Dividends paid - - - - -
Change to inventory -5.10800M -4.96000M -1.38900M -1.97400M -0.38000M
Change to account receivables -61.83700M -53.57200M -37.95700M -28.72500M -22.88500M
Sale purchase of stock 13.18M - 226.27M 116.86M 9.32M
Other cashflows from financing activities 34.92M -222.93500M 10.23M -5.28800M 37.80M
Change to netincome 81.17M 99.99M 41.52M 26.24M 19.43M
Capital expenditures 29.83M 28.07M 13.55M 20.46M 5.18M
Change receivables -61.83700M - -37.95700M -28.72500M -22.88500M
Cash flows other operating 54.51M - 23.14M 22.96M 10.89M
Exchange rate changes - - - - -
Cash and cash equivalents changes -48.73000M - 68.17M 0.44M 11.35M
Change in working capital -65.50900M -46.22800M -56.23500M -29.73400M -13.87000M
Stock based compensation 57.74M 54.53M 41.52M 26.24M 16.33M
Other non cash items 81.30M 6.75M 6.03M 8.99M -2.93100M
Free cash flow -52.84200M -65.82000M -27.31000M -42.32000M -34.24800M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IRTC
iRhythm Technologies Inc		 -3.22 2.60% 120.53 - - 7.15 16.78 7.15 -36.3489
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies Inc

699 8th Street, San Francisco, CA, United States, 94103

Key Executives

Name Title Year Born
Mr. Quentin S. Blackford Pres, CEO & Director 1979
Mr. Douglas J. Devine COO & Sec. 1970
Mr. Mark J. Day Ph.D. Chief Technology Officer 1971
Mr. David A. Vort Strategic Advisor 1966
Mr. Daniel G. Wilson Exec. VP of Corp. Strategy 1982
Mr. Brice Bobzien CPA Chief Financial Officer NA
Dr. Mintu P. Turakhia M.D. Chief Medical Officer & Chief Scientific Officer NA
Mr. Patrick Michael Murphy J.D. Chief Legal Officer 1979
Ms. Reyna M. Fernandez Exec. VP & Chief HR Officer 1967
Mr. Mazi Kiani Sr. VP of Quality & Regulatory NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.